Skip to content

Delta qSOFA for Risk Stratification in Emergency Infected Patients

Prognostic Value of Quick Sequential Organ Failure Assessment Kinetics After Fluids Challenge in the Emergency Department

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02926664
Acronym
DELTASCREEN
Enrollment
512
Registered
2016-10-06
Start date
2016-10-31
Completion date
2017-05-01
Last updated
2017-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Brief summary

The study will investigate the prognostic value of qSOFA (quick Sequential Organ Failure Assessment) kinetics between H0 and H1, and between H0 and H3 in patients with suspicion of Sepsis, i.e. an initial qSOFA of at least of 2.

Detailed description

qSOFA has been reported as a good tool for risk stratification in the ED for patients with infection. However, it is not clear whether qSOFA remains stable during the ED stay, nor whether its kinetics can have prognostic added value. Patients with a qSOFA of at least 2 in the ED, and suspicion of infection will be included. After treatment is initiated and fluids challenge performed, we will collect qSOFA value at 1 hour and 3 hours. Our hypothesis is that a decrease in qSOFA between H0 and H3 is associated with better outcome. We assume that 50% of patients will have a deltaqSOFA \>0, with an overall mortality of 23% (according to previous cohort). Under the hypothesis of difference of at least 15% in mortality between the two groups (DeltaqSOFA \> 0 and Delta qSOFA\<=0), with a power of 90% and an alpha of 0.05, we need to recruit 322 patients.

Interventions

OTHERmeasurement of qSOFA

qSOFA will be measured at H0, H1 and H3

Sponsors

Societe Française de Medecine d'urgence
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* suspicion of infection by the emergency physicians * at least two of the following criteria : respiratory rate \<= 22, systolic blood pressure \<= 100 mmHg and altered mental status

Exclusion criteria

* Infection ruled out by the expert after chart review * patient who refuse to participate

Design outcomes

Primary

MeasureTime frame
In-hospital mortality60 days

Secondary

MeasureTime frame
ICU admission more than 72 hours60 days
ICU admission60 days

Countries

Belgium, France, Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026